Phage Discovery and Phage Therapy
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Biopharmaceuticals".
Deadline for manuscript submissions: 20 March 2025 | Viewed by 795
Special Issue Editor
Special Issue Information
Dear Colleagues,
We are delighted to announce the launch of this Special Issue entitled "Phage Discovery and Phage Therapy". This Special Issue aims to showcase the latest advancements and cutting-edge research in the field of phage biology, with a particular focus on phage discovery and its therapeutic applications.
In recent years, phage therapy has emerged as a new frontier in medical research. The rise of antibiotic-resistant bacteria poses a significant global health challenge, necessitating the exploration of alternative therapeutic approaches. Bacteriophages, also known as phages, are viruses that specifically target and infect bacteria, offering immense potential as powerful tools in combating antibiotic resistance.
The remarkable specificity of phages in recognizing and destroying bacterial pathogens while leaving the surrounding beneficial microbiota intact has garnered considerable attention, making them attractive candidates for the development of targeted antimicrobial therapies. Phage therapy holds great promise not only in treating infections but also in preventing their spread and minimizing the emergence of antibiotic resistance.
We are pleased to invite the submission of original research articles to this Special Issue. The topics to be covered in this Special Issue include, but are not limited to, the following:
- Novel phage discovery: We welcome articles focusing on the identification and characterization of new phages, encompassing their isolation, classification, and genomic analysis.
- Basic phage biology: Manuscripts exploring fundamental aspects of phage biology, such as phage–host interactions, phage replication strategies, and phage evolution, are highly encouraged.
- Phage engineering: We invite papers that delve into the field of phage engineering, including the modification of phages for therapeutic applications, phage-based biocontrol strategies, and phage-mediated gene delivery systems.
- Phage lysins and lysis systems: Research articles focusing on the characterization, engineering, and application of phage-derived lysins and lysis systems for bacterial eradication and antimicrobial therapy are welcomed.
- New advances in methodologies in phage research: Manuscripts describing innovative methodologies, techniques, or tools that advance phage research, such as phage isolation, phage genome sequencing, or high-throughput screening methods, are of particular interest.
We look forward to receiving your valuable contributions and promoting the advancement of knowledge in the field of phage research.
Dr. Sha Liu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- phage discovery
- phage biology
- phage engineering
- phage lysins
- phage therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
